[vc_row][vc_column][vc_column_text]Lymphoma is the most common type of blood cancer, affecting about one in every 50 Americans. Due to advancements and discoveries in lymphoma research since the 1990, survival and recovery rates have increased. Choice of treatment depends on factors such as the type, stage, and grade of the disease, as well as the patient’s overall health and age. The two main sub-groups of lymphomas are Hodgkin’s lymphoma and non-Hodgkin’s lymphoma, which are characterized by unique differences of the cancer. Below is a list of drug options approved by the U.S. Food and Drug Administration (FDA) for patients with lymphoma.

*Note: The following list is not necessarily exhaustive or complete. Lymphoma News Today is not suggesting or recommending any of the therapies for treatment of Lymphoma; the list is merely an index of approved lymphoma drugs and provided as an online resource. Always consult a physician when making treatment choices for lymphoma.

FDA-Approved Drugs To Treat Non-Hodgkin’s Lymphoma

• Abitrexate (Methotrexate)
• Adcetris (Brentuximab Vedotin)
• Ambochlorin (Chlorambucil)
• Amboclorin (Chlorambucil)
• Arranon (Nelarabine)
• Becenum (Carmustine)
• Beleodaq (Belinostat)
• Belinostat
• Bendamustine Hydrochloride
• Bexxar (Tositumomab and Iodine I 131 Tositumomab)
• BiCNU (Carmustine)
• Blenoxane (Bleomycin)
• Bleomycin
• Bortezomib
• Brentuximab Vedotin
• Carmubris (Carmustine)
• Carmustine
• Chlorambucil
• CHOP (drug combination including Cyclophosphamide, Hydroxydaunorubicin, Oncovin and Prednisone)
• Clafen (Cyclophosphamide)
• COPP (drug combination including Cyclophosphamide, Oncovin, Procarbazine Hydrochloride and Prednisone)
• CVP (drug combination including Cyclophosphamide, Vincristine and Prednisolone)
• Cyclophosphamide
• Cytoxan (Cyclophosphamide)
• Denileukin Diftitox
• DepoCyt (Liposomal Cytarabine)
• Dexamethasone
• Doxorubicin Hydrochloride
• EPOCH (drug combination including Etoposide, Prednisone, Oncovin, Cyclophosphamide and Hydroxydaunomycin)
• Folex (Methotrexate)
• Folex PFS (Methotrexate)
• Folotyn (Pralatrexate)
• Hyper-CVAD (drug combination including Cyclophosphamide, Vincristine Sulfate, Adriamycin and Dexamethasone)
• Ibritumomab Tiuxetan
• Ibrutinib
• ICE (drug combination including Ifosfamide, Carboplatin and Etoposide)
• Idelalisib
• Imbruvica (Ibrutinib)
• Intron A (Recombinant Interferon Alfa-2b)
• Istodax (Romidepsin)
• Lenalidomide
• Leukeran (Chlorambucil)
• Linfolizin (Chlorambucil)
• Liposomal Cytarabine
• Mechlorethamine Hydrochloride
• Methotrexate
• Methotrexate LPF (Methotrexate)
• Mexate (Methotrexate)
• Mexate-AQ (Methotrexate)
• Mozobil (Plerixafor)
• Mustargen (Mechlorethamine Hydrochloride)
• Nelarabine
• Neosar (Cyclophosphamide)
• Ontak (Denileukin Diftitox)
• Plerixafor
• Pralatrexate
• Prednisone
• R-CHOP (drug combination including Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin and Prednisone)
• R-CVP (drug combination including Rituximab, Cyclophosphamide, Vincristine and Prednisolone)
• Recombinant Interferon Alfa-2b
• R-EPOCH (drug combination including Rituximab, Etoposide, Prednisone, Oncovin, Cyclophosphamide and Hydroxydaunomycin)
• Revlimid (Lenalidomide)
• Rituxan (Rituximab)
• Rituximab
• Romidepsin
• Tositumomab and Iodine I 131 Tositumomab
• Treanda (Bendamustine Hydrochloride)
• Velban (Vinblastine Sulfate)
• Velcade (Bortezomib)
• Velsar (Vinblastine Sulfate)
• Vinblastine Sulfate
• Vincasar PFS (Vincristine Sulfate)
• Vincristine Sulfate
• Vorinostat
• Zevalin (Ibritumomab Tiuxetan)
• Zolinza (Vorinostat)
• Zydelig (Idelalisib)

FDA-Approved Drugs To Treat Hodgkin’s Lymphoma

• ABVD (drug combination including Adriamycin, Bleomycin, Vincristine Sulfate and Dacarbazine)
• ABVE (drug combination including Adriamycin, Bleomycin, Vincristine Sulfate and Etoposide)
• ABVE-PC (drug combination including Adriamycin, Bleomycin, Vincristine Sulfate, Etoposide, Prednisone and Cyclophosphamide)
• Adcetris (Brentuximab Vedotin)
• Ambochlorin (Chlorambucil)
• Amboclorin (Chlorambucil)
• BEACOPP (drug combination including Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Oncovin, Procarbazine and Prednisolone)
• Becenum (Carmustine)
• BiCNU (Carmustine)
• Blenoxane (Bleomycin)
• Bleomycin
• Brentuximab Vedotin
• Carmubris (Carmustine)
• Carmustine
• COPP (drug combination including Cyclophosphamide, Oncovin, Procarbazine and Prednisolone)
• COPP-ABV (drug combination including Cyclophosphamide, Oncovin, Procarbazine, Prednisolone, Adriamycin, Bleomycin and Vincristine Sulfate)
• Chlorambucil
• Clafen (Cyclophosphamide)
• Cyclophosphamide
• Cytoxan (Cyclophosphamide)
• Dacarbazine
• Doxorubicin Hydrochloride
• DTIC-Dome (Dacarbazine)
• ICE (drug combination including Ifosfamide, Carboplatin and Etoposide)
• Leukeran (Chlorambucil)
• Linfolizin (Chlorambucil)
• Lomustine
• Matulane (Procarbazine Hydrochloride)
• Mechlorethamine Hydrochloride
• MOPP (drug combination including Mechlorethamine Hydrochloride, Oncovin, Procarbazine Hydrochloride and Prednisone)
• Mustargen (Mechlorethamine Hydrochloride)
• Neosar (Cyclophosphamide)
• OEPA (drug combination including Oncovin, Etoposide, Prednisone and Adriamycin)
• OPPA (drug combination including Oncovin, Procarbazine Hydrochloride, Prednisone and Adriamycin)
• Prednisone
• Procarbazine Hydrochloride
• STANFORD V (drug combination including Cyclophosphamide, Mechlorethamine or Ifosfamide in addition to Doxorubicin, Vinblastine, Vincristine, Bleomycin, Etoposide and Prednisone)
• VAMP (drug combination including Vincristine Sulfate, Adriamycin, Methotrexate and Prednisone)
• Velban (Vinblastine Sulfate)
• Velsar (Vinblastine Sulfate)
• Vinblastine Sulfate
• Vincasar PFS (Vincristine Sulfate)
• Vincristine Sulfate

Note: Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

[/vc_column_text][/vc_column][vc_column][vc_row_inner][vc_column_inner width=”1/2″][vc_wp_rss items=”7″ title=”Read the Latest News About Lymphoma” url=”https://lymphomanewstoday.com/tag/lymphoma/feed/”][/vc_column_inner][vc_column_inner width=”1/2″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]